NDC properties for "adalimumab-aaty 80 MG per 0.8 ML Prefilled Syringe" (RxCUI 2668485)
About this data
The tables show NDC propoerties for adalimumab-aaty 80 MG per 0.8 ML Prefilled Syringe with the RxCUI 2668485
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-aaty 80 MG per 0.8 ML Prefilled Syringe (RxCUI 2668485)
| BLA | BLA761219 |
|---|---|
| RxCUI | 2668485 |
| SPL_SET_ID | c44365e9-d470-4e35-978d-8565a9e3471e |
| Prescribable Synonym | adalimumab-aaty 80 MG in 0.8 ML Prefilled Syringe |
| RXNAV_STR | 0.8 ML adalimumab-aaty 100 MG/ML Prefilled Syringe |
| RxNorm Name | 0.8 ML adalimumab-aaty 100 MG/ML Prefilled Syringe |
| RxNorm Synonym | adalimumab-aaty 80 MG per 0.8 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2668485) |
NDC Properties
NDC Item 72606004001
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-01 |
| NDC Item | 72606004001 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004002
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-02 |
| NDC Item | 72606004002 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004003
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-03 |
| NDC Item | 72606004003 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-040-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004001
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-01 |
| NDC Item | 72606004001 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004002
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-02 |
| NDC Item | 72606004002 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004003
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-03 |
| NDC Item | 72606004003 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-040-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004001
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-01 |
| NDC Item | 72606004001 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004002
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-02 |
| NDC Item | 72606004002 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004003
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-03 |
| NDC Item | 72606004003 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-040-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |